Scandinavian Biopharma Holding AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Scandinavian Biopharma Holding AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11298
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Scandinavian Biopharma Holding AB (Scandinavian) is a biotechnology company that distributes vaccines and immunoglobulin. The company offers diagnostics, vaccines, dental and immunoglobulin products. Its products are used in the therapeutic areas of diphtheria and tetanus, tuberculosis, polio, and pertussis. Scandinavian offers contract research and process development services including development strategies, genetic constructions, project management, construction of master and working cell banks; development of fermentation process and down-stream purification, analytical methods development and validation; stability testing, potency assay development, clinical trial services, and others. The company works in partnership with manufacturers within the vaccines, dental and immunoglobulin area. Scandinavian is headquartered in Stockholm, Sweden.

Scandinavian Biopharma Holding AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Scandinavian Biopharma Enters into Agreement with Flynn Pharma 10
Scandinavian Biopharma Enters into Distribution Agreement with Neovii Pharma 11
Scandinavian Biopharma, PATH and University of Gothenburg Amend Agreement to Develop ETEC 12
Scandinavian Biopharma Holding AB – Key Competitors 13
Scandinavian Biopharma Holding AB – Key Employees 14
Scandinavian Biopharma Holding AB – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
Jun 08, 2017: Scandinavian Biopharma continues to grow – 2016 was another successful year 16
Government and Public Interest 17
Apr 25, 2018: Scandinavian Biopharma gets support by the County Administrative Board in Stockholm 17
Other Significant Developments 18
May 22, 2018: Scandinavian Biopharma is once again looking back on a highly successful business year 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Key Facts 2
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scandinavian Biopharma Holding AB, Deals By Therapy Area, 2012 to YTD 2018 8
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Scandinavian Biopharma Enters into Agreement with Flynn Pharma 10
Scandinavian Biopharma Enters into Distribution Agreement with Neovii Pharma 11
Scandinavian Biopharma, PATH and University of Gothenburg Amend Agreement to Develop ETEC 12
Scandinavian Biopharma Holding AB, Key Competitors 13
Scandinavian Biopharma Holding AB, Key Employees 14
Scandinavian Biopharma Holding AB, Subsidiaries 15

List of Figures
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scandinavian Biopharma Holding AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Scandinavian Biopharma Holding AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Donaldson Company, Inc.:戦略・SWOT・企業財務分析
    Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SOGLASIE Insurance Company Ltd.:企業の戦略・SWOT・財務情報
    SOGLASIE Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary SOGLASIE Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Diversicare Healthcare Services Inc (DVCR):製薬・医療:M&Aディール及び事業提携情報
    Summary Diversicare Healthcare Services Inc (Diversicare), formerly Advocat Inc is a healthcare service provider that offers post acute care services and short term rehabilitation and long-term care services to nursing home patients. The company’s services include life steps rehabilitation program, …
  • MISC Bhd (MISC):企業の財務・戦略的SWOT分析
    MISC Bhd (MISC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Etiqa Life and General Assurance Philippines Inc:企業の戦略・SWOT・財務分析
    Etiqa Life and General Assurance Philippines Inc - Strategy, SWOT and Corporate Finance Report Summary Etiqa Life and General Assurance Philippines Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Great Wolf Resorts Inc:戦略・SWOT・企業財務分析
    Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • BG Medicine Inc:医療機器:M&Aディール及び事業提携情報
    Summary BG Medicine Inc (BGM), formerly Beyond Genomics Inc is a medical device company that discovers, develops and delivers diagnostic products. The company offers diagnostis products to aid in the clinical management of heart failure and related disorders. It offers BGM Galectin-3 test, an in vit …
  • Town Health International Medical Group Ltd (3886):企業の財務・戦略的SWOT分析
    Summary Town Health International Medical Group Ltd (THIMGL), formerly Town Health International Investments Ltd, a subsidiary of Hong Kong Health Check and Medical Diagnostic Group Ltd, is a healthcare service provider. The organization offers medical platform, chain clinics, specialty centres, man …
  • Agile Therapeutics Inc (AGRX):医療機器:M&Aディール及び事業提携情報
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • Red Electrica Corporacion SA (REE):企業の財務・戦略的SWOT分析
    Red Electrica Corporacion SA (REE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Atos SE:企業のM&A・事業提携・投資動向
    Atos SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atos SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • HSH Nordbank Private Banking:企業の戦略・SWOT・財務情報
    HSH Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report Summary HSH Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Finbar Group Ltd (FRI):企業の財務・戦略的SWOT分析
    Finbar Group Ltd (FRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • ICICI Bank Ltd:企業の戦略・SWOT・財務情報
    ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • MedStar Health:企業の戦略的SWOT分析
    MedStar Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Bacardi Limited:企業の戦略・SWOT・財務情報
    Bacardi Limited - Strategy, SWOT and Corporate Finance Report Summary Bacardi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pioneer Natural Resources Company:企業のM&A・事業提携・投資動向
    Pioneer Natural Resources Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pioneer Natural Resources Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Allied International Corporation:企業の戦略・SWOT・財務情報
    Allied International Corporation - Strategy, SWOT and Corporate Finance Report Summary Allied International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • ProMIS Neurosciences Inc (PMN):医療機器:M&Aディール及び事業提携情報
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, helps in pred …
  • Isuzu Motors Limited:企業の戦略・SWOT・財務情報
    Isuzu Motors Limited - Strategy, SWOT and Corporate Finance Report Summary Isuzu Motors Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆